See other bills
under the
same topic
        PRIOR PRINTER'S NO. 1256                      PRINTER'S NO. 3691

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 1110 Session of 1997


        INTRODUCED BY NAILOR, MICOZZIE, D. W. SNYDER, MASLAND, GEORGE,
           OLASZ, PETTIT, MANDERINO, SEMMEL, LYNCH, ARGALL, COY, KENNEY,
           BELARDI, C. WILLIAMS, FAIRCHILD, SCRIMENTI, CURRY, PRESTON,
           JOSEPHS, HENNESSEY, TRAVAGLIO, BENNINGHOFF, E. Z. TAYLOR,
           ROHRER, ROBERTS, YOUNGBLOOD, BOSCOLA, TRELLO, RAMOS,
           STEELMAN, MARSICO, ROSS, EGOLF, PETRARCA, L. I. COHEN AND
           SEYFERT, APRIL 2, 1997

        AS REPORTED FROM COMMITTEE ON INSURANCE, HOUSE OF
           REPRESENTATIVES, AS AMENDED, JUNE 8, 1998

                                     AN ACT

     1  Amending the act of May 17, 1921 (P.L.682, No.284), entitled "An
     2     act relating to insurance; amending, revising, and
     3     consolidating the law providing for the incorporation of
     4     insurance companies, and the regulation, supervision, and
     5     protection of home and foreign insurance companies, Lloyds
     6     associations, reciprocal and inter-insurance exchanges, and
     7     fire insurance rating bureaus, and the regulation and
     8     supervision of insurance carried by such companies,
     9     associations, and exchanges, including insurance carried by
    10     the State Workmen's Insurance Fund; providing penalties; and
    11     repealing existing laws," providing for insurance coverage
    12     for treatment of temporomandibular joint dysfunction and
    13     surgery, if medically necessary, for deformities of the
    14     maxilla or mandible.

    15     The General Assembly of the Commonwealth of Pennsylvania
    16  hereby enacts as follows:
    17     Section 1.  The act of May 17, 1921 (P.L.682, No.284), known
    18  as The Insurance Company Law of 1921, is amended by adding a
    19  section to read:
    20     Section 633 634.  Coverage for Treatment of Temporomandibular  <--
    21  Joint Dysfunction and Surgery, if Medically Necessary, for

     1  Deformities of the Maxilla or Mandible.--(a)  (1)  This section   <--
     2  shall apply to any individual or group health, sickness or
     3  accident policy or subscriber contract or certificate issued by
     4  any entity subject to 40 Pa.C.S. Ch. 61 (relating to hospital
     5  plan corporations) or 63 (relating to professional health
     6  service plan corporation), this act, the act of December 29,
     7  1972 (P.L.1701, No.364), known as the "Health Maintenance
     8  Organization Act," or the act of December 14, 1992 (P.L.835,
     9  No.134), known as the "Fraternal Benefit Societies Code," which
    10  provides hospital or medical/surgical coverage.
    11     (2)  NOTHING IN THIS SECTION SHALL APPLY TO ACCIDENT ONLY,     <--
    12  SPECIFIED DISEASE, HOSPITAL INDEMNITY, MEDICARE SUPPLEMENT,
    13  LONG-TERM CARE OR OTHER LIMITED BENEFIT HEALTH INSURANCE
    14  POLICIES.
    15     (b)  If an insurance policy, contract or certificate provides
    16  coverage for benefits to a resident of this Commonwealth, it
    17  shall be deemed to be delivered in this Commonwealth, regardless
    18  of whether the insurer issuing or delivering the policy is
    19  located within or outside of this Commonwealth.
    20     (c)  No policy may be issued for delivery in this
    21  Commonwealth which:
    22     (1)  excludes medically necessary nonsurgical or surgical
    23  treatment for temporomandibular joint dysfunction by
    24  professionals qualified by education, training and experience;
    25  or
    26     (2)  excludes medically necessary surgery for the treatment
    27  of functional deformities of the maxilla and mandible.
    28     (d)  The provisions of this section shall not cover cosmetic
    29  or elective orthodontic or periodontal care or general dental
    30  care.
    19970H1110B3691                  - 2 -

     1     (e)  Nothing in subsection (c)(1) and (2) shall be construed
     2  to prevent the application of the deductible, co-insurance or
     3  pre-existing condition limitation contained in the policy,
     4  contract or certificate.
     5     (f)  A definition of pre-existing condition does not prohibit
     6  an insurer from using an application form designed to elicit the
     7  complete health history of the applicant, and on the basis of
     8  the answers on that application, from underwriting in accordance
     9  with that insurer's established underwriting standards. Unless
    10  otherwise provided in the policy, contract or certificate, a
    11  pre-existing condition need not be covered until the waiting
    12  period is satisfied, as indicated in the policy, contract or
    13  certificate. No policy, contract or certificate may exclude or
    14  use waivers or riders of any kind to exclude, limit or reduce
    15  coverage or benefits for specifically named or described pre-
    16  existing diseases or physical conditions beyond the waiting
    17  period described in the policy, contract or certificate.
    18     (g)  Policies, contracts or certificates shall contain a
    19  twenty-five thousand dollar ($25,000) lifetime maximum for
    20  nonsurgical procedures. The lifetime maximum of the policy shall
    21  be applied to surgical procedures. The twenty-five thousand
    22  dollar ($25,000) lifetime maximum for nonsurgical procedures
    23  does not prevent the company from exercising the option to grant
    24  additional benefits for nonsurgical procedures if it is more
    25  cost effective than providing benefits for surgery.
    26     (h)  Ninety (90) days after a nonsurgical procedure, the
    27  provider of treatment is required to provide documentation and a
    28  narrative, signed by the patient, to the insurer showing the
    29  progress of the insured. If the documentation and narrative do
    30  not show satisfactory progress, benefits are terminated until a
    19970H1110B3691                  - 3 -

     1  second opinion is received. If the second opinion differs from
     2  the treating provider, a revised treatment plan is required. If
     3  the second opinion, due to a valid reason, does not differ from
     4  the current treatment, the current treatment shall be continued
     5  for an additional ninety (90) days at which time the treatment
     6  plan will be re-evaluated.
     7     (i)  Insurers shall require preauthorization for coverage,
     8  and providers of treatment shall use a uniform preauthorization
     9  request form and follow certain standards which include
    10  evidence-based standards and patient-centered standards in
    11  determining whether treatment is medically necessary. The
    12  following apply:
    13     (1)  An insurer shall require a preauthorization for
    14  nonsurgical treatment, and the provider of treatment shall
    15  submit a properly completed Temporomandibular Joint Dysfunction
    16  Nonsurgical Treatment Preauthorization Request Form.
    17     (2)  An insurer shall require a preauthorization for surgical
    18  treatment for coverage, and the provider of treatment shall
    19  submit a properly completed Temporomandibular Joint Dysfunction
    20  Surgical Treatment Preauthorization Request Form.
    21     (3)  In cases of emergency, the preauthorization form shall
    22  be submitted no later than forty-eight (48) hours after the
    23  emergency treatment. Providers are permitted only two (2)
    24  emergencies with the same patient within one (1) week without
    25  preauthorization prior to treatment providing the
    26  preauthorization is submitted no later than forty-eight (48)
    27  hours after the emergency treatment.
    28     (4)  The following are standards and requirements for
    29  evaluation of claims for temporomandibular dysfunction for
    30  medical necessity:
    19970H1110B3691                  - 4 -

     1     (i)  To evaluate appropriately a claim for treatment of this
     2  disorder, the existence of a skeletal and/or muscular
     3  dysfunction shall be documented.
     4     (ii)  Any maldevelopment that is not treatable with
     5  conventional, reversible, nonsurgical treatment, yielding a
     6  stable and functional post-treatment occlusion without worsening
     7  the patient's original condition, shall be a covered surgical
     8  procedure.
     9     (iii)  Indications for nonsurgical and PROCEDURES IN EXCESS    <--
    10  OF TWO HUNDRED DOLLARS ($200) AND ALL surgical treatments shall
    11  include evidence of the following:
    12     (A)  Physical evidence of musculoskeletal, dento-osseous or
    13  soft tissue deformity.
    14     (B)  Imaging evidence of musculoskeletal, dento-osseous or
    15  soft tissue deformity.
    16     (C)  Malocclusion deviating from a normal occlusal
    17  relationship that cannot reasonably be corrected by nonsurgical
    18  means such as orthodontics or prosthetics. This item is
    19  applicable only as evidence for indication of surgical
    20  treatment.
    21     (D)  Inability to open or close the jaw adequately based on
    22  medically accepted range of motion standards. These ranges are
    23  as follows:  forty-eight (48) to fifty-two (52) millimeters
    24  vertical and twelve (12) to fourteen (14) millimeters lateral.
    25  Adherence to these measurements is recommended. Any deviation
    26  should be justified in a report as part of the evidence.
    27     (E)  A patient history, including the patient's perception of
    28  pain, dysfunction and the impact on the patient's quality of
    29  life.
    30     (iv)  The following data shall be submitted so that claims
    19970H1110B3691                  - 5 -

     1  may be evaluated appropriately:
     2     (A)  A narrative of the patient's clinical condition in
     3  conjunction with the Temporomandibular Joint Dysfunction
     4  Nonsurgical or Surgical Treatment Preauthorization Form.
     5     (B)  Mounted study models with appropriate centric record and
     6  transcranial x-ray or preferably a corrected tomography. This
     7  data may be substituted with appropriate paper documentation
     8  using current United States Food and Drug Administration-
     9  approved computer imaging systems, for example, MRI, that have
    10  the ability to photograph all necessary information.
    11     (j)  This section shall not be construed to affect any other
    12  coverage required under the acts under subsection (a) or to
    13  restrict the scope of coverage under any policy, contract or
    14  certificate issued or delivered in this Commonwealth to any
    15  individual or group.
    16     (k)  Nothing in this section shall be construed to encourage
    17  surgical procedures over appropriate nonsurgical procedures.
    18     (l)  As used in this section, the term "functional deformity"
    19  means a deformity of the bone or joint structure of the maxilla
    20  or mandible such that the normal character and essential
    21  function of such bone structure is impeded. A "temporomandibular
    22  joint" means the connection of the mandible and the temporal
    23  bone through the articular disc surrounded by the joint capsule
    24  and associated ligaments and tendons. "Temporomandibular joint
    25  dysfunction" means congenital or developed anomalies of the
    26  temporomandibular joint. An "emergency" means a condition in
    27  which immediate medical care is necessary to prevent serious
    28  impairment or the death of the individual.
    29     Section 2.  This act shall take effect in 60 days.

    A15L40BIL/19970H1110B3691        - 6 -